Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Etigilimab (OMP-313M32), a humanized IgG1 monoclonal antibody, inhibits TIGIT from interacting with PVR (CD155; poliovirus receptor) and suppresses subsequent signaling, resulting in target cell death [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Etigilimab (OMP-313M32), a humanized IgG1 monoclonal antibody, inhibits TIGIT from interacting with PVR (CD155; poliovirus receptor) and suppresses subsequent signaling, resulting in target cell death [1]. |
Synonyms | OMP-313M32 |
Molecular Weight | N/A |
CAS No. | 2044984-83-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Etigilimab 2044984-83-8 OMP-313M32 inhibitor inhibit